Report overview
Diabetes management platform is a digital tool for diabetics and high risk individuals that allow users to self-manage their treatment and directly connect with specialists. These digital tools improves the Quality of Life (QoL) and reduces the health related costs to users. These platforms helps the patient to track health data, connect to specialist, engage in a community exchange, and allows access to knowledge resources and practical tips about diabetes management. These platforms includes advisory applications for smart insulin pens and smartphone based artificial pancreas system that automatically regulates the insulin delivery, reduces the hypoglycaemic attacks and significantly improves the blood glucose level. These tools equip healthcare professionals with data-driven insights into patient?s habits, areas of risk and opportunities for parameter changes.
This report contains market size and forecasts of Diabetes Management Platform in Global, including the following market information:
Global Diabetes Management Platform Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Management Platform market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Web Application Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Management Platform include GLUKOA, TypeZero Technologies, BioTelemetry, CELLNOVO, STARsystem By Sanofi, WellDoc, Tactio Health and Livongo Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Management Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Management Platform Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Management Platform Market Segment Percentages, by Type, 2021 (%)
Web Application
Mobile Application
SMS/USSD Application
Global Diabetes Management Platform Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Management Platform Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers
Global Diabetes Management Platform Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetes Management Platform Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Management Platform revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Management Platform revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GLUKOA
TypeZero Technologies
BioTelemetry
CELLNOVO
STARsystem By Sanofi
WellDoc
Tactio Health
Livongo Health
